InflaRx N.V. SEC filings IFRX
InflaRx N.V. has 289 filings in SEC EDGAR's recent list, going back to Jun 23, 2017. Its latest annual report, Form 20-F, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 12, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2025 | — |
| CORRESP | Letter to the SEC | Jun 3, 2025 | — |
| UPLOAD | Letter from the SEC | May 22, 2025 | — |
| EFFECT | Filing | Jul 11, 2023 | — |
| CORRESP | Letter to the SEC | Jul 7, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2023 | — |
| EFFECT | Filing | Jul 17, 2020 | — |
| CORRESP | Letter to the SEC | Jul 16, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2020 | — |
| EFFECT | Filing | May 3, 2018 | — |
| CORRESP | Letter to the SEC | May 2, 2018 | — |
| CORRESP | Letter to the SEC | May 2, 2018 | — |
| DRSLTR | Filing | May 2, 2018 | — |
| UPLOAD | Letter from the SEC | May 1, 2018 | — |
| DRSLTR | Filing | May 1, 2018 | — |
| DRS | Filing | Apr 23, 2018 | — |
| POS EX | Form pos ex | Nov 9, 2017 | — |
| CT ORDER | Filing | Nov 8, 2017 | — |
| CERTNAS | Auto-generated paper document | Nov 7, 2017 | — |
| EFFECT | Filing | Nov 7, 2017 | — |
| 8-A12B | Form 8-a12b | Nov 7, 2017 | — |
| CORRESP | Letter to the SEC | Nov 3, 2017 | — |
| CORRESP | Letter to the SEC | Nov 3, 2017 | — |
| CORRESP | Letter to the SEC | Oct 31, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2017 | — |
| CORRESP | Letter to the SEC | Oct 30, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 27, 2017 | — |
| CORRESP | Letter to the SEC | Oct 26, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2017 | — |
| CORRESP | Letter to the SEC | Oct 18, 2017 | — |
| CORRESP | Letter to the SEC | Oct 13, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2017 | — |
| DRSLTR | Filing | Sep 11, 2017 | — |
| DRS/A | Filing | Sep 11, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2017 | — |
| DRSLTR | Filing | Aug 3, 2017 | — |
| DRS/A | Filing | Aug 3, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2017 | — |
| DRS | Filing | Jun 23, 2017 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IFRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Jena, Germany
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1708688
- Former names
- Fireman B.V. (until Nov 8, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.